Abstract
Foreword
The global economic downturn that began in 2008 has slowed growth in nearly
all technology sectors, including biotechnology markets. Nonetheless, the high
value that biotechnology products can deliver, and the long-term growth
potential of the sector will surely result in increased capital input and
long-term sustained growth when the global economy recovers.
BCC Research has provided comprehensive coverage of biotechnology markets for
many years, and we are now increasing our production of biotechnology market
research reports. This review of biotechnology market research conducted in
2008 and the first half of 2009 is meant to provide a sampling of the type of
quantitative market information, analysis and guidance that has been aiding
business decision-making since BCC was founded in 1971.
This review includes highlights of reports published by BCC Research on the
following biotechnology markets:
- Synthetic Biology
- Commercial Amino Acids
- Monoclonal Therapeutics and Companion Diagnostic Products
- Environmental Markets for Biotechnology
- Protein Drugs
- Botanical and Plant-derived Drugs
- Stem Cells
- RNA Interference
- DNA Diagnostics
- Biologic Imaging Reagents
|